As of 2021, approximately 537 million adults are currently living with diabetes, across the world. This number is projected to rise to 643 million by 2030 and 783 million by 2045. Given the high level of support and treatment costs associated...

Diabetes affects over 422M people worldwide each year. Given the high level of clinician support and treatment costs associated with this disease, DTx in diabetes products are uniquely positioned to treat patients with diabetes and reduce out...

  As organizations in the life sciences industry look to opportunities to generate greater returns and increase efficiencies, there’s a growing interest in AI-driven R&D processes among other aspects of the value chain. Netscribes ...

The COVID-19 pandemic has accelerated the demand for digital health services. With the healthcare sector at the forefront of this crisis, digital health presented itself as a perfect solution to transform healthcare into a more accessible, da...

Life sciences industry’s response to COVID-19 disruptions has evolved over the course of the year. The SARS-CoV-2 virus, first emerged as an unknown pneumonia-like disease in December 2019, and ultimately gained the status of a global h...

Formulating an ethical and potent vaccine against novel pathogens typically takes years. Globally, scientists, pharmaceutical firms, and regulators are arduously working to answer the most palpable question – a COVID-19 vaccine. While clini...

The rapid spread of the COVID-19 pandemic has redefined the global landscape, forcing governments and organizations to re-evaluate their legacy approach to business. In this report, we look at how the pandemic is affecting the adoption of 3D ...

Artificial Intelligence (AI) is bringing about a paradigm shift in healthcare, powered by the increasing availability of medical data and the rapid progress of analytical techniques. From catalyzing drug discovery to using data-driven diagnos...

The global biosimilar market is expected to reach USD 36 billion by 2022. However, only some countries are favorable for biosimilars due to reasons ranging from poor accessibility to unconducive regulatory environments. This infographic takes...

Connect with us
X
  • I agree to receive updates on the latest industry trends, products and services from Netscribes.
  • We respect your right to data privacy and security. You may unsubscribe from our communications at any time. For more information, check out our Privacy Policy.